Industry Trend

Site Sections

Menu








© 2023. All Rights reserved.

Overview for SHIONOGI

All Data per March 2, 2023

Industry:

Drug Manufacturers—Specialty & Generic

Last Close:

6,039.00 JPY

Expected Dividend:

1.99 %

Payoffs per Year:

2.0
Business Summary
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. Its primary products Tivicay for HIV treatment; Mulpleta for the treatment of thrombocytopenia; Xofluza, an influenza drug; Symproic for opioid-induced constipation treatment; and Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment. The company also offers antibody detection kits for COVID-19. Shionogi & Co., Ltd. has collaboration agreements with InveniAI, LLC.; Hsiri Therapeutics Inc.; Nagasaki University; Roche Group to develop and commercialize Xofluza; and Nagasaki University and The Kitasato Institute to develop antimalarial drugs and vaccines. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.

Competitors View

Ordering

MERCK KGAA

GER		 1.06 1.75%
1.13%		 4.16% 1.93% 1.0 6.9
-9.48%		 23.3 11.04% 47.04 1.0

SHIONOGI

JPN
 0.93 1.58%
1.99%		 4.3% 1.75% 1.0 4.25
-16.73%		 22.76 -6.97% 84.7 2.0

HIKMA PHARMACEUTICALS

GBR		 1.11 1.38%
2.39%		 5.42% 1.61% 1.0 0.7
-50.72%		 20.04 6.65% 56.11 3.0

SUMITOMO DAINIPPON PHARMA

JPN		 0.88 1.22%
3.33%		 1.09% 1.17% 1.0 0.22
-62.09%		 16.98 9.14% 44.38 4.0

EISAI

JPN		 1.12 2.76%
0.0%		 0.0% 2.53% 1.0 0.95
-23.18%		 44.21 -30.92% 64.51 5.0

ZOETIS

USA		 1.0 0.67%
0.76%		 8.43% 0.9% 1.0 -inf
0.0%		 17.13 9.35% 32.68 6.0

PERRIGO COMPANY

USA		 0.95 0.65%
2.68%		 6.42% 0.79% 1.0 -0.41
-76.82%		 32.42 -66.67% 49.41 7.0

DERMAPHARM

GER		 0.88 1.16%
5.46%		 4.02% 1.27% -0.5 -inf
0.0%		 29.76 12.15% 35.35 8.0

TAKEDA PHARMACEUTICAL

JPN		 1.06 3.88%
0.0%		 0.0% 3.55% -1.0 -0.23
-50.99%		 37.82 22.16% 40.06 9.0

KANGMEI PHARMACEUTICAL

CHN		 0.98 1.12%
nan%		 0.0% 1.03% 0.0 -0.17
-88.01%		 227.16 505.79% 61.83 nan

Information for SHIONOGI

Yield Triangle

Dividend & Close

Close Dividend Return (%)
Year
2012 1,437.00 40.00 2.78
2013 2,280.00 44.00 1.93
2014 3,125.00 48.00 1.54
2015 5,503.00 56.00 1.02
2016 5,599.00 68.00 1.21
2017 6,097.00 76.00 1.25
2018 6,271.00 88.00 1.40
2019 6,767.00 100.00 1.48
2020 5,635.00 106.00 1.88
2021 8,125.00 108.00 1.33
2023 6,039.00 120.18 1.99

Fundamentals

Chart